Why the study?
Carotid intima-media thickness predicts cardiovascular disease, but its significance as an independent prognostic factor for cardiovascular morbidity and mortality in patients with chronic kidney disease and type 2 diabetes required investigation.
Does high carotid intima-media thickness predict all-cause mortality and cardiovascular events in patients with type 2 diabetes and chronic kidney disease?
Does high carotid intima-media thickness predict all-cause mortality and cardiovascular events in patients with type 2 diabetes and chronic kidney disease?
Answers are grounded in this paper and cite their sources.
Increased carotid intima-media thickness (>0.86 mm) is a strong independent predictor of all-cause mortality and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
BACKGROUND: Intima-Media-Thickness of the carotid artery wall (cIMT) is a strong predictor of cardiovascular (CV) disease. The aim of this study was to investigate the significance of cIMT as an independent prognostic factor for CV morbidity and mortality in patients with chronic kidney disease (CKD) and diabetes mellitus type 2 (DM2). METHODS: The study included 142 diabetic patients in different stages of CKD. Patients were categorized into two groups according to low (≤0.86 mm) or high cIMT (>0.86 mm), respectively. CV events and death from all causes were registered during a seven-year follow-up. RESULTS: and 15 years (range: 5-40), respectively. Patients with increased cIMT were older, suffered from a lower estimated glomerular filtration rate (eGFR), peripheral atherosclerosis and plaque presence in either carotid artery. Increased BMI (beta= -0.29, p = .01), lower eGFR (beta = 0.353, p = .003) and male gender (beta= -0.339, p = .005) were found to predict increased cIMT. Predictors of all-cause mortality in Cox proportional hazard models were low eGFR and high cIMT with HR = 0.96 (CI = 0.94-0.98), p < .001 and HR = 2.9 (CI = 1.03-7.99), p = .04, respectively. The risk of future CV event was determined by albuminuria and cIMT with HR = 1 (CI = 1.0-1.0), p < .001 and HR = 2.04 (CI = 1.1-3.78), p = .02, respectively. Patients with high cIMT presented significantly higher all-cause mortality and a new CV event (p = .005/p = .018, respectively). CONCLUSIONS: cIMT is a strong and independent predictor of CV morbidity and mortality, and should be considered a valuable tool for the stratification of CV risk in patients with CKD and DM2.
No takes yet. Share an insight, caveat, or question.
Roumeliotis et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: